EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Elbit Systems (ESLT)

Aerospace & Defense

Alembic Global Advisors

Alembic are reiterating their Overweight rating on shares of ESLT and are raising their target price by USD4 to US265. ESLT shares have been weak YTD, particularly recently, due, Alembic believe, to political factors. One manifestation of such factors is France’s recent decision to bar Israeli firms from the upcoming Eurosatory defense conference. Despite such issues, they do not believe the fundamentals support a weakening in ESLT shares and believe there is meaningful upside from here. As such, Alembic reiterate their Overweight rating. Their 15.5x terminal valuation is ~5% premium to the S&P 500 on FY1 EV/EBITDA and Alembic believe there is likely room for valuation upside should ESLT’s focus on margin rate and cash flow begin to bear fruit.

Edition: 188

- 14 June, 2024